← All organizations

Orlando Immunology Center

Academic/HospitalWebsite ↗

Also known as: Charlotte-Paige Rolle, MD | Orlando Immunology Center

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

May 1, 2022

Timeline

No events for the selected filters.

Drugs by trial phase (13 distinct, 8 trials)

Phase 4 (6 own, 0 via acquisition)

Phase 2 (6 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

pro-140 monoclonal antibody

Indications

Studied for

Recent trials (11)

NCT05220358Overall official - principal investigatorPhase 4May 1, 2022
NCT05220358Lead sponsorPhase 4May 1, 2022
NCT04983030CollaboratorPhase 1/Phase 2Aug 1, 2021
NCT04585737Lead sponsorPhase 4Sep 22, 2020
NCT04585737Sponsor investigatorPhase 4Sep 22, 2020
NCT04585737Overall official - principal investigatorPhase 4Sep 22, 2020
NCT03721510CollaboratorPhase 1/Phase 2Dec 3, 2018
NCT02759042Overall official - principal investigatorN/AApr 19, 2016
NCT00675844CollaboratorPhase 2May 1, 2008
NCT00380159Overall official - principal investigatorPhase 2Sep 1, 2006
NCT00312039Overall official - principal investigatorPhase 1/Phase 2Mar 1, 2006

Details

Founded: Orlando, FL, US
Last known activity: May 1, 2022